Company record
Samm Solutions, Inc., d.b.a. BTS Research
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Samm Solutions, Inc., d.b.a. BTS Research.
Warning letters
-
DrugsSamm Solutions, Inc., d.b.a. BTS Research
FDA warned San Diego lab BTS Research that it violated good laboratory practice rules for nonclinical drug studies, citing unreliable data recording and archiving.
Medium